Syphilis is a bacterial infection caused by Treponema pallidum subsp. pallidum Infection with T. pallidum subsp. pallidum and its dissemination lead to the synthesis of proinflammatory cytokines triggered by the interaction of bacterial lipoproteins with Toll-like receptor 2 (TLR2). TLR2 contains several nonsynonymous single-nucleotide polymorphisms that may impact the activation of its signaling cascade and alter the responsiveness to, or the course of, various infectious diseases, including those caused by pathogenic spirochetes. To investigate whether TLR2 polymorphism may influence susceptibility to syphilis, 221 healthy individuals with no history of syphilis (controls) and 137 patients diagnosed with syphilis (cases) were screened for the presence of the Arg753Gln polymorphism in the TLR2 gene (2258G→A; rs5743708). The Arg753Gln variant occurs at a significantly lower frequency in syphilis patients (4 of 137 [3%]) than in controls (24 of 221 [10.9%]). These data suggest that TLR2 Arg753Gln may protect from the development of syphilis due to reduced signaling.

Department of Biology Faculty of Medicine Masaryk University Brno Czech Republic

Department of Dermatology 1st Faculty of Medicine Charles University Prague Prague Czech Republic

Department of Medical Microbiology Faculty of Medicine Masaryk University Brno Czech Republic

National Reference Laboratory for Diagnostics of Syphilis The National Institute for Public Health Prague Czech Republic

Zobrazit více v PubMed

Mahla RS, Reddy MC, Prasad DVR, Kumar H. 2013. Sweeten PAMPs: role of sugar complexed PAMPs in innate immunity and vaccine biology. Front Immunol 4:248. doi:10.3389/fimmu.2013.00248. PubMed DOI PMC

Lien E, Sellati TJ, Yoshimura A, Flo TH, Rawadi G, Finberg RW, Carrol JD, Espevik T, Ingalls RR, Radolf JD, Golenbock DT. 1999. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 274:33419–33425. doi:10.1074/jbc.274.47.33419. PubMed DOI

Kang TJ, Yeum CE, Kim BC, You EY, Chae GT. 2004. Differential production of interleukin-10 and interleukin-12 in mononuclear cells from leprosy patients with a Toll-like receptor 2 mutation. Immunology 112:674–680. doi:10.1111/j.1365-2567.2004.01926.x. PubMed DOI PMC

Ben-Ali M, Barbouche MR, Bousnina S, Chabbou A, Dellagi K. 2004. Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin Diagn Lab Immunol 11:625–626. doi:10.1128/CDLI.11.3.625-626.2004. PubMed DOI PMC

Ozen S, Berdeli A, Türel B, Kutlay S, Yalcinkaya F, Arici M, Besbas N, Bakkaloglu A, Yilmaz E. 2006. Arg753Gln TLR-2 polymorphism in familial Mediterranean fever: linking the environment to the phenotype in a monogenic inflammatory disease. J Rheumatol 33:2498–2500. PubMed

Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA. 2000. A novel polymorphism in the Toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 68:6398–6401. doi:10.1128/IAI.68.11.6398-6401.2000. PubMed DOI PMC

Texereau J, Chiche JD, Taylor W, Choukroun G, Comba B, Mira JP. 2005. The importance of Toll-like receptor 2 polymorphisms in severe infections. Clin Infect Dis 41(Suppl 7):S408–S415. doi:10.1086/431990. PubMed DOI

Schröder NW, Schumann RR. 2005. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 5:156–164. doi:10.1016/S1473-3099(05)01308-3. PubMed DOI

Marra CM, Sahi SK, Tantalo LC, Ho EL, Dunaway SB, Jones T, Hawn TR. 2014. Toll-like receptor polymorphisms are associated with increased neurosyphilis risk. Sex Transm Dis 41:440–446. doi:10.1097/OLQ.0000000000000149. PubMed DOI PMC

Schröder NWJ, Diterich I, Zinke A, Eckert J, Draing C, von Baehr V, Hassler D, Priem S, Hahn K, Michelsen KS, Hartung T, Burmester GR, Göbel UB, Hermann C, Schumann RR. 2005. Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease. J Immunol 175:2534–2540. doi:10.4049/jimmunol.175.4.2534. PubMed DOI

Cédola M, Chiani Y, Pretre G, Alberdi L, Vanasco B, Gómez RM. 2015. Association of Toll-like receptor 2 Arg753Gln and Toll-like receptor 1 Ile602Ser single-nucleotide polymorphisms with leptospirosis in an Argentine population. Acta Trop 146:73–80. doi:10.1016/j.actatropica.2015.03.007. PubMed DOI

Sellati TJ, Bouis DA, Kitchens RL, Darveau RP, Pugin J, Ulevitch RJ, Gangloff SC, Goyert SM, Norgard MV, Radolf JD. 1998. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that used by lipopolysaccharide. J Immunol 160:5455–5464. PubMed

Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, Maitland M, Norgard MV, Plevy SE, Smale ST, Brennan PJ, Bloom BR, Godowski PJ, Modlin RL. 1999. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285:732–736. doi:10.1126/science.285.5428.732. PubMed DOI

Ioana M, Ferwerda B, Plantinga TS, Stappers M, Oosting M, McCall M, Cimpoeru A, Burada F, Panduru N, Sauerwein R, Doumbo O, van der Meer JWM, van Crevel R, Joosten LAB, Netea MG. 2012. Different patterns of Toll-like receptor 2 polymorphisms in populations of various ethnic and geographic origins. Infect Immun 80:1917–1922. doi:10.1128/IAI.00121-12. PubMed DOI PMC

de Voux A, Kidd S, Grey JA, Rosenberg ES, Gift TL, Weinstock H, Bernstein KT. 2017. State-specific rates of primary and secondary syphilis among men who have sex with men — United States, 2015. MMWR Morb Mortal Wkly Rep 66:349–354. doi:10.15585/mmwr.mm6613a1. PubMed DOI PMC

Kiechl S, Wiedermann CJ, Willeit J. 2003. Toll-like receptor 4 and atherogenesis. Ann Med 35:164–171. doi:10.1080/07853890310008215. PubMed DOI

Schott E, Witt H, Neumann K, Taube S, Oh D-Y, Schreier E, Vierich S, Puhl G, Bergk A, Halangk J, Weich V, Wiedenmann B, Berg T. 2007. A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection. J Hepatol 47:203–211. doi:10.1016/j.jhep.2007.03.021. PubMed DOI

Citores MJ, Baños I, Noblejas A, Rosado S, Castejon R, Cuervas-Mons V. 2011. Toll-like receptor 3 L412F polymorphism may protect against acute graft rejection in adult patients undergoing liver transplantation for hepatitis C-related cirrhosis. Transplant Proc 43:2224–2226. doi:10.1016/j.transproceed.2011.05.011. PubMed DOI

Johnson CM, Lyle EA, Omueti KO, Stepensky VA, Yegin O, Alpsoy E, Hamann L, Schumann RR, Tapping RI. 2007. A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J Immunol 178:7520–7524. doi:10.4049/jimmunol.178.12.7520. PubMed DOI

Takahashi M, Chen Z, Watanabe K, Kobayashi H, Nakajima T, Kimura A, Izumi Y. 2011. Toll-like receptor 2 gene polymorphisms associated with aggressive periodontitis in Japanese. Open Dent J 5:190–194. doi:10.2174/1874210601105010190. PubMed DOI PMC

Ferwerda B, McCall MBB, Alonso S, Giamarellos-Bourboulis EJ, Mouktaroudi M, Izagirre N, Syafruddin D, Kibiki G, Cristea T, Hijmans A, Hamann L, Israel S, ElGhazali G, Troye-Blomberg M, Kumpf O, Maiga B, Dolo A, Doumbo O, Hermsen CC, Stalenhoef AFH, van Crevel R, Brunner HG, Oh DY, Schumann RR, de la Rúa C, Sauerwein R, Kullberg BJ, van der Ven AJAM, van der Meer JWM, Netea MG. 2007. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc Natl Acad Sci U S A 104:16645–16650. doi:10.1073/pnas.0704828104. PubMed DOI PMC

Pasare C, Medzhitov R. 2003. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299:1033–1036. doi:10.1126/science.1078231. PubMed DOI

O’Garra A, Vieira P. 2007. TH1 cells control themselves by producing interleukin-10. Nat Rev Immunol 7:425–428. doi:10.1038/nri2097. PubMed DOI

Medvedev AE. 2013. Toll-like receptor polymorphisms, inflammatory and infectious diseases, allergies, and cancer. J Interferon Cytokine Res 33:467–484. doi:10.1089/jir.2012.0140. PubMed DOI PMC

Hu L, Tao H, Tao X, Tang X, Xu C. 2019. TLR2 Arg753Gln gene polymorphism associated with tuberculosis susceptibility: an updated meta-analysis. Biomed Res Int 2019:2628101. doi:10.1155/2019/2628101. PubMed DOI PMC

Tantalo LC, Lukehart SA, Marra CM. 2005. Treponema pallidum strain-specific differences in neuroinvasion and clinical phenotype in a rabbit model. J Infect Dis 191:75–80. doi:10.1086/426510. PubMed DOI

Marra CM, Sahi SK, Tantalo LC, Godornes C, Reid T, Behets F, Rompalo A, Klausner JD, Yin YP, Mulcahy F, Golden MR, Centurion-Lara A, Lukehart SA. 2010. Enhanced molecular typing of Treponema pallidum: geographical distribution of strain types and association with neurosyphilis. J Infect Dis 202:1380–1388. doi:10.1086/656533. PubMed DOI PMC

Flood JM, Weinstock HS, Guroy ME, Bayne L, Simon RP, Bolan G. 1998. Neurosyphilis during the AIDS epidemic, San Francisco, 1985–1992. J Infect Dis 177:931–940. doi:10.1086/515245. PubMed DOI

Marra CM, Maxwell CL, Smith SL, Lukehart SA, Rompalo AM, Eaton M, Stoner BP, Augenbraun M, Barker DE, Corbett JJ, Zajackowski M, Raines C, Nerad J, Kee R, Barnett SH. 2004. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 189:369–376. doi:10.1086/381227. PubMed DOI